|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent AKCA insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why AKCA insider buys are important for investors to follow.
Date | Insider | Price | Amount |
10-10-2020 Insider Buy |
Pharmaceuticals Inc Ionis >10% Owner |
$18.15
CAGR »
|
$385,464,527.25 21,237,715 shares |
4-17-2018 Insider Buy |
Pharmaceuticals Inc Ionis >10% Owner |
$18.75
CAGR »
|
$199,999,987.50 10,666,666 shares |
7-19-2017 Insider Buy |
Pharmaceuticals Inc Ionis >10% Owner |
$8.00
CAGR »
|
$25,000,000.00 3,125,000 shares |
Also See: Institutional Holders of AKCA
Also See: SEC filings
Below we present the annualized performance delivered by AKCA stock since 10-10-2020 (the date of the most recent
insider purchase). The performance of the investment from the time AKCA insider buying occurred is the ultimate
test of whether insiders were right about AKCA being a good buy.
AKCA -- use the split history when considering split-adjusted past price performance.
AKCA Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent AKCA insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding AKCA
|
|